title: Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients.
abstract: OBJECTIVE
  To compare mortality risk among cadaveric renal transplant recipients vs transplant candidates on dialysis in the cyclosporine era.
  
  
  METHODS
  Patient mortality risk was analyzed by treatment modality for a completed statewide patient population.
  
  
  METHODS
  All Michigan residents younger than age 65 years who started endstage renal disease (ESRD) therapy between January 1, 1984, and December 31, 1989, were included. Patients were followed up from ESRD onset (n = 5020), to wait-listing for renal transplant (n = 1569), to receiving a cadaveric first transplant (n = 799), and to December 31, 1989.
  
  
  METHODS
  Mortality rates.
  
  
  RESULTS
  Using a time-dependent variable based on the waiting time from date of wait-listing to transplantation and adjusting for age, sex, race, and primary cause of ESRD, the relative risk (RR) of dying was increased early after transplantation and then decreased to a beneficial long-term effect, given survival to 365 days after transplantation (RR, 0.36; P < .001). This lower long-term risk was most pronounced (RR, 0.25) among diabetic transplant recipients compared with diabetic wait-listed dialysis patients (P < .001) and not observed among patients with glomerulonephritis as cause of ESRD (P > .05). Overall, the estimated times from transplantation to equal mortality risk was 117 +/- 28 days and to equal cumulative mortality was 325 +/- 91 days.
  
  
  CONCLUSIONS
  The overall mortality risk following renal transplantation was initially increased, but there was a long-term survival benefit compared with similar patients on dialysis. These analyses allow improved description of comparative mortality risks for dialysis and transplant patients and allow advising patients regarding comparative survival outcomes.
authors.affiliation: Michigan Kidney Registry, University of Michigan School of Medicine, Ann Arbor.
authors.forename: F K
authors.initials: FK
authors.lastname: Port
authors.forename: R A
authors.initials: RA
authors.lastname: Wolfe
authors.forename: E A
authors.initials: EA
authors.lastname: Mauger
authors.forename: D P
authors.initials: DP
authors.lastname: Berling
authors.forename: K
authors.initials: K
authors.lastname: Jiang
mesh_terms: D002102:Cadaver; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000628:therapy*; D016030:Kidney Transplantation / Q000401:mortality*; D008297:Male; D008824:Michigan / Q000453:epidemiology; D016016:Proportional Hazards Models; D006435:Renal Dialysis / Q000401:mortality*; D016019:Survival Analysis; D013997:Time Factors; D009927:Tissue and Organ Procurement / Q000706:statistics & numerical data*